160 related articles for article (PubMed ID: 16939882)
21. Overcoming aspirin resistance: increased platelet inhibition with combination aspirin and clopidogrel and high dose aspirin therapy in aspirin resistant patients with peripheral vascular disease.
Wong S; Morel-Kopp MC; Chen Q; Appleberg M; Ward CM; Lewis DR
Thromb Haemost; 2006 Jun; 95(6):1042-3. PubMed ID: 16732389
[No Abstract] [Full Text] [Related]
22. Vascular adhesion molecule-1 and markers of platelet function before and after a treatment with iloprost or a supervised physical exercise program in patients with peripheral arterial disease.
Arosio E; Minuz P; Prior M; Zuliani V; Gaino S; De Marchi S; Fontana L; Andrioli G; Lechi C; Lechi A
Life Sci; 2001 Jun; 69(4):421-33. PubMed ID: 11459433
[TBL] [Abstract][Full Text] [Related]
23. Microcirculation and tolerability following i.v. infusion of PGE1 and iloprost: a randomized cross-over study in patients with critical limb ischemia.
Schellong S; Altmann E; von Bilderling P; Rudofsky G; Waldhausen P; Rogatti W
Prostaglandins Leukot Essent Fatty Acids; 2004 Jun; 70(6):503-9. PubMed ID: 15120713
[TBL] [Abstract][Full Text] [Related]
24. Effect of Iloprost infusion on metabolism in critical limb ischemia, utilizing microdialysis. A pilot study.
Danielsson P; Metzsch C; Norgren L
Int Angiol; 2004 Sep; 23(3):259-62. PubMed ID: 15765041
[TBL] [Abstract][Full Text] [Related]
25. [Prostacyclin (iloprost) as an adjuvant in local surgical therapy of stage IV arterial occlusive disease--is quantification of the therapeutic effect possible with tcPO2 measurements?].
Breuer C; Abri O
Vasa; 1995; 24(1):62-71. PubMed ID: 7536999
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of a conservative treatment with iloprost in severe peripheral occlusive arterial disease (POAD). GISAP Study.
Int Angiol; 1994 Mar; 13(1):70-4. PubMed ID: 7521384
[TBL] [Abstract][Full Text] [Related]
27. A randomized, double-blind, crossover comparison of iloprost with dextran in patients with peripheral arterial occlusive disease.
Ylitalo P; Kaukinen S; Reinikainen P; Salenius JP; Vapaatalo H
Int J Clin Pharmacol Ther Toxicol; 1990 May; 28(5):197-204. PubMed ID: 1694831
[TBL] [Abstract][Full Text] [Related]
28. Infusion of a stable prostacyclin analogue, iloprost, to patients with peripheral vascular disease: lack of antiplatelet effect but risk of thromboembolism.
Kovacs IB; Mayou SC; Kirby JD
Am J Med; 1991 Jan; 90(1):41-6. PubMed ID: 1702580
[TBL] [Abstract][Full Text] [Related]
29. Two randomised and placebo-controlled studies of an oral prostacyclin analogue (Iloprost) in severe leg ischaemia. The Oral Iloprost in severe Leg Ischaemia Study Group.
Eur J Vasc Endovasc Surg; 2000 Oct; 20(4):358-62. PubMed ID: 11038148
[TBL] [Abstract][Full Text] [Related]
30. Asymmetric dimethylarginine is associated with macrovascular disease and total homocysteine in patients with type 2 diabetes.
Krzyzanowska K; Mittermayer F; Krugluger W; Schnack C; Hofer M; Wolzt M; Schernthaner G
Atherosclerosis; 2006 Nov; 189(1):236-40. PubMed ID: 16414052
[TBL] [Abstract][Full Text] [Related]
31. [Modification of some prothrombotic indices after treatment with iloprost in arterial disease patients].
Ferlito S; Bonomo T; Costa R; Di Salvo MM; Attanasio L; Finocchiaro PM; Condorelli M; Mazzone D
Minerva Cardioangiol; 1996 Dec; 44(12):645-8. PubMed ID: 9053818
[TBL] [Abstract][Full Text] [Related]
32. Dobutamine effect on ankle-brachial pressure index in patients with peripheral arterial occlusive disease. New noninvasive test for evaluation of peripheral circulation?
Wysokinski WE; Spittell PC; Pellikka PA; Miller WL; Seward JB
Int Angiol; 1998 Sep; 17(3):201-7. PubMed ID: 9821035
[TBL] [Abstract][Full Text] [Related]
33. A meta-analysis of randomized placebo control trials in Fontaine stages III and IV peripheral occlusive arterial disease.
Loosemore TM; Chalmers TC; Dormandy JA
Int Angiol; 1994 Jun; 13(2):133-42. PubMed ID: 7525794
[TBL] [Abstract][Full Text] [Related]
34. Combined administration of nitric oxide gas and iloprost during cardiopulmonary bypass reduces platelet dysfunction: a pilot clinical study.
Chung A; Wildhirt SM; Wang S; Koshal A; Radomski MW
J Thorac Cardiovasc Surg; 2005 Apr; 129(4):782-90. PubMed ID: 15821644
[TBL] [Abstract][Full Text] [Related]
35. Effects of iloprost on salt-sensitive Dahl rats.
Somova L
Methods Find Exp Clin Pharmacol; 1995 Sep; 17(7):443-7. PubMed ID: 8577205
[TBL] [Abstract][Full Text] [Related]
36. Iloprost, stable analogue of the prostacyclin, is able to improve the tissue resistance to ischaemia.
Andreozzi GM; Di Pino L; Li Pira M; Butto G; Martini R; Signorelli S
Int Angiol; 1994 Mar; 13(1):68-9. PubMed ID: 7521383
[TBL] [Abstract][Full Text] [Related]
37. A human model of platelet-leucocyte adhesive interactions during controlled ischaemia in patients with peripheral vascular disease.
Pasqualini L; Pirro M; Lombardini R; Ciuffetti G; Dragani P; Mannarino E
J Clin Pathol; 2002 Dec; 55(12):946-50. PubMed ID: 12461065
[TBL] [Abstract][Full Text] [Related]
38. The prostacyclin analogue iloprost increases circulating endothelial progenitor cells in patients with critical limb ischemia.
Di Stefano R; Barsotti MC; Melillo E; Iorio M; Santoni T; Armani C; Dell'omodarme M; Ristori C; De Caterina R; Balbarini A
Thromb Haemost; 2008 Nov; 100(5):871-7. PubMed ID: 18989532
[TBL] [Abstract][Full Text] [Related]
39. The effects of iloprost infusion on microcirculation is independent of nitric oxide metabolites and endothelin-1 in chronic peripheral ischaemia.
Mazzone A; Cusa C; Bucci L; Vezzoli M; Ghio S; Buggia I; Regazzi MB; Fossati G; Mazzucchelli I; Gritti D
Eur J Clin Invest; 1999 Jan; 29(1):1-5. PubMed ID: 10092981
[TBL] [Abstract][Full Text] [Related]
40. Hemodynamic, hemorheologic, and hemocoagulative changes after treatment with picotamide in patients affected by peripheral arterial disease (PAD) of the lower limbs.
Neirotti M; Molaschi M; Ponzetto M; Macchione C; Poli L; Bonino F; Fabris F
Angiology; 1994 Feb; 45(2):137-41. PubMed ID: 8129189
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
